Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

CBRAIN: a web-based, distributed computing platform for collaborative neuroimaging research.
BENEFIT 8-year results provide further support for the long-term value of early treatment of multiple sclerosis.
The incidence of clinically isolated syndrome in a multi-ethnic cohort.
Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosis.
Physiological variation of retinal layer thickness is not caused by hydration: A randomised trial.
[New aspects in the therapy of multiple sclerosis and optic neuritis.]
Heterogeneity of cortical lesions in multiple sclerosis: Clinical and pathologic implications.
Excitability decreasing central motor plasticity is retained in multiple sclerosis patients.
The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper.
Resting-state functional connectivity in multiple sclerosis: An examination of group differences and individual differences.
Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis.
Diagnostic ability of a new method for measuring haemoglobin levels in the optic nerve head in multiple sclerosis patients.
Exercise therapy and multiple sclerosis: a systematic review.
The Use of Focus Groups to Characterize Symptoms in Persons With Multiple Sclerosis.
Cellular immune responses in multiple sclerosis patients treated with interferon-beta.
Differentiating patterns of oligoclonal banding in the cerebrospinal fluid and the diagnosis of multiple sclerosis.
Aryl hydrocarbon receptor and kynurenine: recent advances in autoimmune disease research.
Core muscle strength and endurance measures in ambulatory persons with multiple sclerosis: validity and reliability.
Multiple sclerosis: Cannabis use is associated with deleterious brain changes in patients with multiple sclerosis.
Epigenetics in autoimmune diseases: Pathogenesis and prospects for therapy.
Neurophysiological Correlates of Central Fatigue in Healthy Subjects and Multiple Sclerosis Patients before and after Treatment with Amantadine.
The Diagnosis and Treatment of Optic Neuritis.
Cost-Effectiveness Modeling in Multiple Sclerosis: Playing Around with Non-Healthcare Costs?
BAX inhibitor-1 is a Ca(2+) channel critically important for immune cell function and survival.
Is β-catenin neutralization cross-involved in the mechanisms mediated by natalizumab action?

Pages